Answer
Atrial fibrillation and atrial flutter have been observed during pirtobrutinib (Jaypirca) treatment, particularly in patients with a history of atrial fibrillation and/or multiple cardiovascular comorbidities.
Sources for this answer
- Jaypirca 50mg, 100mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked